Institution statistics

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - France 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:20
Total Project Funding per Partner:11
Total Number of Projects:27
2018
Criterium:Position:
Overall Score:27
Total Project Funding per Partner:16
Total Number of Projects:35
Networking Rank (Reputation):74
2017
Criterium:Position:
Overall Score:28
Total Project Funding per Partner:14
Total Number of Projects:30
Networking Rank (Reputation):75
2016
Criterium:Position:
Overall Score:28
Total Project Funding per Partner:15
Total Number of Projects:28
Networking Rank (Reputation):60
2015
Criterium:Position:
Overall Score:33
Total Project Funding per Partner:18
Total Number of Projects:26
Networking Rank (Reputation):71
Partner Constancy:100-200
Project Leadership Index:31
2014
Criterium:Position:
Overall Score:43
Total Project Funding per Partner:10
Total Number of Projects:14
Networking Rank (Reputation):47
Partner Constancy:57
Project Leadership Index:47
Diversity Index:200-300
2013
Criterium:Position:
Overall Score:39
Total Project Funding per Partner:14
Total Number of Projects:22
Total Project Funding:39
Partner Constancy:27
Project Leadership Index:8
Diversity Index:46
2012
Criterium:Position:
Overall Score:58
Total Project Funding per Partner:33
Total Number of Projects:26
Total Project Funding:34
Networking Rank (Reputation):69
Networking Rank (Reputation):69
Partner Constancy:19
Project Leadership Index:20
Diversity Index:42
2011
Criterium:Position:
Overall Score:55
Total Project Funding per Partner:14
Total Number of Projects:22
Total Project Funding:26
Networking Rank (Reputation):63
Partner Constancy:45
Project Leadership Index:24
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:15
Total Project Funding per Partner:10
Total Number of Projects:14
Total Project Funding:4
Networking Rank (Reputation):20
Partner Constancy:11
Project Leadership Index:32
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:38
Total Project Funding per Partner:21
Total Number of Projects:20
Total Project Funding:36
Networking Rank (Reputation):56
Partner Constancy:71
Project Leadership Index:15
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:23
Total Project Funding per Partner:15
Total Number of Projects:13
Total Project Funding:13
Networking Rank (Reputation):25
Partner Constancy:38
Project Leadership Index:31
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:13
Total Project Funding per Partner:16
Total Number of Projects:9
Total Project Funding:7
Networking Rank (Reputation):16
Partner Constancy:50
Project Leadership Index:38
Diversity Index:800-900
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 590
As coordinator: 78
As participant: 381
Sole participant: 131
Coordinator / Participant Ratio: 0.2*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 295.062 19.889.282 1.573.468 1 4
2020 116.661.272 404.890.260 67.918.790 25 31
2019 116.111.799 261.728.042 47.023.954 21 31
2018 53.216.669 313.927.876 39.575.606 18 18
2017 6.945.616 164.821.798 38.217.588 10 33
2016 48.266.214 213.530.283 40.416.459 15 34
2015 29.040.703 191.105.025 36.435.884 19 36
2014 10.795.578 90.666.437 39.152.636 15 29
2013 52.316.255 220.673.785 44.851.352 21 39
2012 16.730.877 147.621.637 20.516.387 19 32
2011 27.629.164 189.912.427 31.850.509 21 38
2010 47.402.388 324.065.875 44.130.625 24 56
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE55
UNIVERSITY COLLEGE LONDON53
KAROLINSKA INSTITUTE51
INSERM TRANSFERT46
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE45
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM42
KATHOLIEKE UNIVERSITEIT LEUVEN37
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD36
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS35
CHARITE UNIVERSITAETSMEDIZIN BERLIN35
STICHTING KATHOLIEKE UNIVERSITEIT35
COMMISSARIAT A L'ENERGIE ATOMIQUE33
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT30
KING'S COLLEGE LONDON30
UNIVERSITAIR MEDISCH CENTRUM UTRECHT29
ACADEMISCH ZIEKENHUIS GRONINGEN26
EUROPEAN MOLECULAR BIOLOGY LABORATORY26
MEDIZINISCHE UNIVERSITAET WIEN26
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM25
INSTITUT PASTEUR25
THE UNIVERSITY OF MANCHESTER25
CONSIGLIO NAZIONALE DELLE RICERCHE24
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE24
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV23
THE UNIVERSITY OF EDINBURGH23
EBERHARD KARLS UNIVERSITAET TUEBINGEN22
SERVICIO MADRILENO DE SALUD22
UNIVERSITY OF COPENHAGEN22
UNIVERSITE DE GENEVE21
UPPSALA UNIVERSITET21
INSTITUTO DE SALUD CARLOS III20
REGION HOVEDSTADEN20
TARTU ULIKOOL20
UNIVERSITAET ZUERICH20
UNIVERSITAET ULM19
UNIVERSITEIT GENT18
UNIVERSITEIT MAASTRICHT18
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER17
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE17
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK17
MEDICAL RESEARCH COUNCIL17
UNIVERSITAETSKLINIKUM FREIBURG17
UNIVERSITY OF NEWCASTLE UPON TYNE17
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS16
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH16
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN16
OSPEDALE PEDIATRICO BAMBINO GESU16
UNIVERSITY OF GLASGOW16
UNIVERSITY OF HELSINKI16
PHILIPPS UNIVERSITAET MARBURG15
THE UNIVERSITY OF SHEFFIELD15
UNIVERSITA DEGLI STUDI DI TORINO15
UNIVERSITAETSKLINIKUM HEIDELBERG15
ACADEMISCH ZIEKENHUIS LEIDEN14
DEPARTMENT OF HEALTH14
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V14
GOETEBORGS UNIVERSITET14
ISTITUTO SUPERIORE DI SANITA14
LUNDS UNIVERSITET14
MEDIZINISCHE UNIVERSITAT GRAZ14
NATIONAL UNIVERSITY OF IRELAND GALWAY14
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON14
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA13
GENOME RESEARCH13
MEDIZINISCHE HOCHSCHULE HANNOVER13
TECHNISCHE UNIVERSITAET DRESDEN13
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE13
THE UNIVERSITY OF LIVERPOOL13
UNIVERSITE D'AIX MARSEILLE13
UNIVERSITE LIBRE DE BRUXELLES13
UNIVERSITEIT UTRECHT13
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN13
UNIVERSITY OF BIRMINGHAM13
UNIVERSITY OF BRISTOL13
UNIVERSITY OF DUNDEE13
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV12
NOVARTIS PHARMA12
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS12
THE UNIVERSITY OF NOTTINGHAM12
UNIVERSITA DEGLI STUDI DI PADOVA12
UNIVERSITEIT ANTWERPEN12
FUNDACAO PARA A CIENCIA E A TECNOLOGIA11
JANSSEN PHARMACEUTICA NV11
MOSAIQUES DIAGNOSTICS11
RIJKSUNIVERSITEIT GRONINGEN11
THE UNIVERSITY OF WARWICK11
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA11
UNIVERSITY OF OSLO11
WEIZMANN INSTITUTE OF SCIENCE11
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER11
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE10
FOLKEHELSEINSTITUTTET10
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA10
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT10
INSTITUT CURIE10
KLINIKUM DER UNIVERSITAET ZU KOELN10
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN10
MASARYKOVA UNIVERZITA10
MINISTRY OF HEALTH10
OULUN YLIOPISTO10
Constancy:

Total number of partners:6230

Partner loyalty:
Frequent Partner: (> 2 projects): 4050
Rare Partner: 2180

Frequent / Rare Partner Ratio: 1.86

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES196
RTD HORIZONTAL TOPICS97
SOCIAL AND ECONOMIC CONCERNS27
INDUSTRY AND TECHNOLOGY18
ENERGY3
AGRICULTURE AND MARINE RESOURC2
PHYSICAL AND EXACT SCIENCES2
PROTECTING MAN AND HIS ENVIRON2

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells. INTERCEPT-MDSparticipant3.120.45610
2021-01-01The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease HT4PDcoordinator295.0621
2021-01-01Systems approach of URban enviRonmEnts and heALth SURREALparticipant3.887.29710
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2021-01-01Oligonucleotides for Medical Applications OLIGOMEDparticipant4.153.34412
2020-12-01Coherent Raman Imaging for the Molecular Study of the OrigiN of diseases CRIMSONparticipant5.132.80110
2020-12-01Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA ORCHESTRAparticipant19.887.64226
2020-11-01Population Health Information Research Infrastructure PHIRIparticipant4.980.32832
2020-11-01Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy EVERESTparticipant1.499.9252
2020-11-01Market Release of a Portable Device for COVID-19 at the Point-of-Care; a Global Diagnostics Approach IRIS-COVparticipant2.384.8788
2020-10-01Graphene Flagship 2D Experimental Pilot Line 2D-EPLparticipant20.000.000172
2020-10-01Unravelling the secretion machinery for virulence factors in apicomplexan parasites KissAndSpitRhoptrycoordinator2.496.2101
2020-10-01Using cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental path KILL-OR-DIFFERENTIATparticipant9.377.1514
2020-09-21MITHAML – Exploring the role of Metabolic IntraTumoral Heterogeneity in drug resistance of Acute Myeloid Leukemia in vivo MITHAMLcoordinator257.6202
2020-09-01Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM RadoNormparticipant18.000.00056
2020-09-01X-eHealth: eXchanging electronic Health Records in a commom framework X-eHealthparticipant2.999.98034
2020-09-01Using PML nuclear body biology to identify potential AML treatment targets PMLingAMLcoordinator184.7081
2020-09-01Photodynamic therapy triggered by spectral scanner CT: an efficient tool for cancer treatment SCANnTREATparticipant2.999.9555
2020-09-01Biophysics of circulating tumor cells, from single molecule to cell clusters BiCiClecoordinator184.7081
2020-09-01BioInspired Clicked Siderophore-Antibiotics ANTIBIOCLICKScoordinator2.000.0001
2020-07-01Gender and Health Inequalities : from embodiment to health care cascade GENDHIcoordinator9.974.4472
2020-07-01European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases EU-RESPONSEcoordinator15.719.45021
2020-07-01The evolution of menstruation in primates EVOMENScoordinator1.185.2501
2020-06-01Development of Innovative Therapeutic Strategies for beta-hemoglobinopathies DITSBcoordinator2.000.0001
2020-06-01Oncometabolitic control of tumor growth and epileptogenesis in IDH mutated gliomas: D2HG signaling mechanism. GliomaSignalscoordinator1.875.1351
2020-06-01Controlling epileptic brain networks with computationally optimized weak electric fields GALVANIcoordinator9.998.1773
2020-05-01Exposure to ‘cocktails’ of food additives and chronic disease risk ADDITIVEScoordinator2.000.0002
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00021
2020-04-01Graphene Flagship Core Project 3 GrapheneCore3participant150.000.000165
2020-04-01Validation of a novel antiviral drug candidate against influenza FluAttackcoordinator150.0002
2020-04-01P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis MetEpiCcoordinator196.7081
2020-04-01Rapid interaction profiling of 2019-nCoV for network-based deep drug-repurpose learning (DDRL) RiPCoNparticipant1.230.6353
2020-04-01Effective and Affordable Flu Vaccines for the World INDIGOparticipant9.975.97916
2020-04-01Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity EDUC8coordinator2.100.7098
2020-04-01Early defects in the dynamic of the spinal sensorimotor network: is ALS a post-natal neurodevelopmental disorder ? ADELEcoordinator190.6762
2020-03-16Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic I-MOVE-COVID-19participant2.808.16326
2020-03-01Molecular basis of human enhanceropathies ENHPATHYcoordinator3.992.39715
2020-03-01Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe ISLETparticipant7.999.9997
2020-02-14Rapid European SARS-CoV-2 Emergency research Response RECoVERparticipant19.995.19514
2020-02-01ONCOgenic Receptor Network of Excellence and Training 2.0 ONCORNET2.0participant4.099.78210
2020-01-01Advancing Tools for Human Early Lifecourse Exposome Research and Translation ATHLETEparticipant11.998.33422
2020-01-01Exposome project for health and occupational research EPHORparticipant11.981.85219
2020-01-01Visualizing Death Inducing Protein Complexes VIDECparticipant1.237.40010
2020-01-01MOnitoring Outbreak events for Disease surveillance in a data science context MOODparticipant13.910.74716
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAcoordinator4.822.19710
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bcoordinator9.983.02914
2020-01-01European Virus Archive GLOBAL EVA-GLOBALparticipant11.602.74935
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2020-01-01Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases LONGITOOLSparticipant11.997.44918

overview shows latest 50 from 590 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum